UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive income/(loss)
Beginning balance (in shares) at Dec. 31, 2020		50,879
Beginning balance at Dec. 31, 2020	$ 151,724	$ 5	$ 128,930	$ 22,793	$ (4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	(2,062)			(2,062)
Stock-based compensation	5,671		5,671
Exchange of warrants into common stock (in shares)		2,221
Exchange of warrants into common stock	0
Exercise of stock options (in shares)		41
Exercise of stock options	162		162
Issuance of shares and payments of tax obligations resulted from net share settlement of vested stock awards (in shares)		1,030
Issuance of shares and payments of tax obligations resulted from net share settlement of vested stock awards	(15,297)		(15,297)
Foreign currency translation adjustments, net of tax	49				49
Ending balance (in shares) at Mar. 31, 2021		54,171
Ending balance at Mar. 31, 2021	140,247	$ 5	119,466	20,731	45
Beginning balance (in shares) at Dec. 31, 2021		66,851
Beginning balance at Dec. 31, 2021	227,051	$ 7	212,077	15,093	(126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	(2,667)			(2,667)
Stock-based compensation	8,661		8,661
Exercise of stock options (in shares)		72
Exercise of stock options	292		292
Issuance of shares and payments of tax obligations resulted from net share settlement of vested stock awards (in shares)		134
Issuance of shares and payments of tax obligations resulted from net share settlement of vested stock awards	(1,802)		(1,802)
Foreign currency translation adjustments, net of tax	(283)				(283)
Ending balance (in shares) at Mar. 31, 2022		67,057
Ending balance at Mar. 31, 2022	$ 231,252	$ 7	$ 219,228	$ 12,426	$ (409)